Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q2 2022 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The question asks: does management convey that deals, orders, contracts, projects, customers, sites, or programs it is landing NOW are individually bigger, broader, or longer than the ones it was landing for the same offering not long ago, so that each new instance of essentially the same business is worth more to the company than the last? We need to look for evidence in the transcript. Management discusses various segments: Urban Solutions, Mining & Metals, Advanced Technologies, Mission Solutions, Energy Solutions, NuScale. We need to see if they explicitly compare current deal sizes to past ones for the same kind of business. Key points from the call: - New awards in Q2 were $3.6 billion, book-to-burn above 1:1. Margins on new awards were 550 basis points above plan. But that's about margins, not size. - Urban Solutions: new awards $1.9 billion, including I-35 project. They mention legacy projects and inflation. No mention of increasing size of individual projects. - Mining & Metals: they mention converting prospects, awards for Iluka rare earths refinery, copper project in Indonesia. They say "Over the next three quarters our Mining & Metals clients are positioning to move forward on approximately $5 billion of limited and full notice to proceed awards." That's about pipeline, not necessarily larger individual deals. - Advanced Technologies: semiconductors, life sciences. They mention working with Intel on projects in Arizona and Malaysia, and anticipate full release of work. No size comparison. - Mission Solutions: Savannah River extension for four years. That's a longer contract, but is it larger? They say "multibillion dollar program" but no comparison to past. - Energy Solutions: awards include large lithium chemicals project, refinery upgrade, Fortress Energy FAST LNG 2. They mention "repeatable models" for LNG. But no explicit statement that each new LNG project is larger than the previous. - NuScale: they mention their investment value, but not about deal size. The question is specifically about "successive engagements of the same kind coming in at progressively larger size." Management does not explicitly state that the size of individual contracts is escalating.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.